RNA, U6 small nuclear 1051, pseudogene (RNU6-1051P)

RNA, U6 small nuclear 1051, pseudogene (RNU6-1051P) is a pseudogene of the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is an essential component of the major spliceosome, involved in the removal of introns from pre-mRNA, but pseudogenes like RNU6-1051P do not code for functional RNA and do not play a direct biological role[1][3][6]. U6 snRNA pseudogenes arise through retrotransposition processes and serve as genomic markers for studying retrotransposition events rather than having a confirmed biological function[6]. Pseudogenes of U6 snRNA are not considered therapeutic targets, do not have validated disease associations, do not serve as biomarkers, and do not interact with drugs. Their presence in the genome is largely non-functional, and the term pseudogene indicates that RNU6-1051P does not produce active or functional RNA[6][2]. Key data points: - This target is a pseudogene, not a functional gene or protein product. - It is not considered a drug target, receptor, enzyme, or other typical pharmacological entity. - Pseudogenes do not have established biological functions, disease associations, biomarkers, safety profiles, or mechanisms of drug action. - The entry is "incorrect" for a therapeutic target query because pseudogenes like RNU6-1051P are not drug targets, receptors, or enzymes. - The canonical name is already standardized as "RNA, U6 small nuclear 1051, pseudogene" with abbreviation "RNU6-1051P". In summary, RNU6-1051P is a pseudogene of U6 snRNA and is not recognized as a therapeutic or biological target[6][2].

Other names

RNU6-1051PU6 snRNA pseudogene 1051